Durongpisitkul, K., Chungsomprasong, P., Vijarnsorn, C., Chanthong, P., Kanjanauthai, S., & Soongswang, J. (2021). Improved low-risk criteria scores for combination therapy of sildenafil and generic bosentan in patients with congenital heart disease with severe pulmonary hypertension: A prospective open label study. JRSM Cardiovasc Dis.
Style de citation ChicagoDurongpisitkul, Kritvikrom, Paweena Chungsomprasong, Chodchanok Vijarnsorn, Prakul Chanthong, Supaluck Kanjanauthai, et Jarupim Soongswang. "Improved Low-risk Criteria Scores for Combination Therapy of Sildenafil and Generic Bosentan in Patients With Congenital Heart Disease With Severe Pulmonary Hypertension: A Prospective Open Label Study." JRSM Cardiovasc Dis 2021.
Style de citation MLADurongpisitkul, Kritvikrom, et al. "Improved Low-risk Criteria Scores for Combination Therapy of Sildenafil and Generic Bosentan in Patients With Congenital Heart Disease With Severe Pulmonary Hypertension: A Prospective Open Label Study." JRSM Cardiovasc Dis 2021.